Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimotuzumab with Radio-chemotherapy for Childhood Brainstem Tumor
NCT02672241Phase 2Unknown
- Sponsor
- Xinhua Hospital
- Start
- Jan 2016
- Primary completion
- Aug 2019
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nimotuzumab in brainstem glioma, sponsored by Xinhua Hospital. Status: unknown.
02
Drugs
nimotuzumab
03
Conditions
brainstem glioma
Beyond the preview
Go deeper on NCT02672241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02672241.